AKT1 and prostate cancer: Syntenin-1 over-expression can enhance cancer cell migration via the activation of focal adhesion kinase-JNK or focal adhesion kinase-Akt signalling [9], and in turn, influence the aggressiveness of prostate cancer cells [34] and effectively contribute to cancer progression [35].